PKK suppresses tumor growth and is decreased in squamous cell carcinoma of the skin

Journal of Investigative Dermatology

Volumn 135, Issue 3, 2015, Pages 869-876

  Poligone, Brian ^a   Gilmore, Elaine S ^a   Alexander, Carolina V ^a   Oleksyn, David ^a   Gillespie, Kathleen ^a   Zhao, Jiyong ^b   Ibrahim, Sherrif F ^a   Pentland, Alice P ^a   Brown, Marc D ^a   Chen, Luojing ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE; PROTEIN KINASE C; PROTEIN KINASE C ASSOCIATED KINASE; PROTEIN P63; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; ANKRD3 PROTEIN, HUMAN; CKAP4 PROTEIN, HUMAN; MEMBRANE PROTEIN; PROTEIN SERINE THREONINE KINASE; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; SKIN CARCINOGENESIS; SKIN CARCINOMA; TUMOR XENOGRAFT; ANIMAL; CARCINOGENESIS; CASE CONTROL STUDY; CELL CYCLE; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; NONOBESE DIABETIC MOUSE; PATHOLOGY; PHYSIOLOGY; SCID MOUSE; SIGNAL TRANSDUCTION; SKIN; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; XENOGRAFT;

ANIMALS; APOPTOSIS; CARCINOGENESIS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELL CYCLE; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROGRAFTS; HUMANS; KERATINOCYTES; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED NOD; MICE, SCID; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SKIN; SKIN NEOPLASMS;

EID: 84922678375     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.428     Document Type: Article

References (42)

1. Adams S, Munz B (2010) RIP4 is a target of multiple signal transduction pathways in keratinocytes: implications for epidermal differentiation and cutaneous wound repair. Exp Cell Res 316:126-37
2. Adams S, Pankow S, Werner S et al. (2007) Regulation of NF-kappaB activity and keratinocyte differentiation by the RIP4 protein: implications for cutaneous wound repair. J Invest Dermatol 127:538-44
3. Antonini D, Russo MT, De Rosa L et al. (2010) Transcriptional Repression of miR-34 Family Contributes to p63-Mediated Cell Cycle Progression in Epidermal Cells. J Invest Dermatol 130:1249-57
4. Brash DE (2006) Roles of the transcription factor p53 in keratinocyte carcinomas. Br J Dermatol 154(Suppl 1):8-10
5. Dajee M, Lazarov M, Zhang JY et al. (2003) NF-[kappa]B blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 421:639-43
6. Heim D, Cornils K, Schulze K et al. (2014) Retroviral insertional mutagenesis in telomerase-immortalized hepatocytes identifies RIPK4 as novel tumor suppressor in human hepatocarcinogenesis. Oncogene; e-pub ahead of print 13 January 2014; doi:10.1038/onc.2013.551
7. Holland P, Willis C, Kanaly S et al. (2002) RIP4 is an ankyrin repeat-containing kinase essential for keratinocyte differentiation. Curr Biol 12:1424-8
8. Huang X, McGann JC, Liu BY et al. (2013) Phosphorylation of dishevelled by protein kinase RIPK4 regulates Wnt signaling. Science 339:1441-5
9. Jacobs MS, Persons DL, Fraga GR (2013) EGFR and MYC gene copy number aberrations are more common in squamous cell carcinoma than keratoacanthoma: a FISH study. J Cutan Pathol 40:447-54
10. Kalay E, Sezgin O, Chellappa V et al. (2012) Mutations in RIPK4 cause the autosomal-recessive form of popliteal pterygium syndrome. Am Hum Genet 90:76-85
11. Karia PS, Han J, Schmults CD (2013) Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. J Am Acad Dermatol 68:957-66
12. Kim RH, Armstrong AW (2012) Nonmelanoma skin cancer. Dermatol Clin 30:125-39. ix
13. Kim SW, Oleksyn DW, Rossi RM et al. (2008) Protein kinase C-Associated kinase is required for NF-kappaB signaling and survival in diffuse large B-cell lymphoma cells. Blood 111:1644-53
14. Li G, Tron V, Ho V (1998) Induction of squamous cell carcinoma in p53-deficient mice after ultraviolet irradiation. J Invest Dermatol 110:72-5
15. Li Q, Sambandam SA, Lu HJ et al. (2011) 14-3-3sigma and p63 play opposing roles in epidermal tumorigenesis. Carcinogenesis 32:1782-8
16. Mantel A, Carpenter-Mendini A, VanBuskirk J et al. (2014) Aldo-keto Reductase 1C3 (AKR1C3) is overexpressed in skin squamous cell carcinoma (SCC) and affects SCC growth via prostaglandin metabolism. Exp Dermatol 23:573-8
17. Meylan E, Martinon F, Thome M et al. (2002) RIP4 (DIK/PKK), a novel member of the RIP kinase family, activates NF-kappa B and is processed during apoptosis. EMBO Rep 3:1201-8
18. Meylan E, Tschopp J (2005) The RIP kinases: crucial integrators of cellular stress. Trends Biochem Sci 30:151-9
19. Miliani de Marval PL, Macias E, Conti CJ et al. (2004) Enhanced malignant tumorigenesis in Cdk4 transgenic mice. Oncogene 23:1863-73
20. Mills AA, Zheng B, Wang XJ et al. (1999) p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398:708-13
21. Mortier L, Marchetti P, Delaporte E et al. (2002) Progression of actinic keratosis to squamous cell carcinoma of the skin correlates with deletion of the 9p21 region encoding the p16(INK4a) tumor suppressor. Cancer Lett 176:205-14
22. Muto A, Ruland J, McAllister-Lucas LM et al. (2002) Protein kinase C-Associated kinase (PKK) mediates Bcl10-independent NF-kappa B activation induced by phorbol ester. J Biol Chem 277:31871-6
23. Parker SB, Eichele G, Zhang P et al. (1995) p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 267:1024-7
24. Poligone B, Hayden MS, Chen L et al. (2013) A role for NF-kappaB activity in skin hyperplasia and the development of keratoacanthomata in mice. PLoS One 8:e71887
25. Proweller A, Tu L, Lepore JJ et al. (2006) Impaired notch signaling promotes de novo squamous cell carcinoma formation. Cancer Res 66:7438-44
26. Ren Q, Kari C, Quadros MR et al. (2006) Malignant transformation of immortalized HaCaT keratinocytes through deregulated nuclear factor kappaB signaling. Cancer Res 66:5209-15
27. Rogers HW, Weinstock MA, Harris AR et al. (2010) Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 146:283-7
28. Rountree RB, Willis CR, Dinh H et al. (2010) RIP4 regulates epidermal differentiation and cutaneous inflammation. J Invest Dermatol 130: 102-12
29. Seitz CS, Lin Q, Deng H et al. (1998) Alterations in NF-kappaB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-kappaB. Proc Natl Acad Sci USA 95:2307-12
30. Su X, Cho MS, Gi YJ et al. (2009) Rescue of key features of the p63-null epithelial phenotype by inactivation of Ink4a and Arf. EMBO J 28: 1904-15
31. Sur I, Ulvmar M, Jungedal R et al. (2009) Inhibition of NF-kappaB signaling interferes with phorbol ester-induced growth arrest of keratinocytes in a TNFR1-independent manner. J Recept Signal Transduct Res 29:44-51
32. Takao J, Yudate T, Das A et al. (2003) Expression of NF-kappaB in epidermis and the relationship between NF-kappaB activation and inhibition of keratinocyte growth. Br J Dermatol 148:680-8
33. Truong AB, Kretz M, Ridky TW et al. (2006) p63 regulates proliferation and differentiation of developmentally mature keratinocytes. Genes Dev 20:3185-97
34. van Bokhoven H, Hamel BC, Bamshad M et al. (2001) p63 Gene mutations in eec syndrome, limb-mammary syndrome, and isolated split hand-split foot malformation suggest a genotype-phenotype correlation. Am J Hum Genet 69:481-92
35. van Hogerlinden M, Rozell BL, Ahrlund-Richter L et al. (1999) Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling. Cancer Res 59:3299-303
36. Wang X, Zhu W, Zhou Y et al. (2014) RIPK4 is downregulated in poorly differentiated tongue cancer and is associated with migration/invasion and cisplatin-induced apoptosis. Int J Biol Markers 29:e150-9
37. Westfall MD, Mays DJ, Sniezek JC et al. (2003) The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations. Mol Cell Biol 23:2264-76
38. Wullaert A, Bonnet MC, Pasparakis M (2011) NF-[kappa]B in the regulation of epithelial homeostasis and inflammation. Cell Res 21:146-58
39. Xiong Y, Hannon GJ, Zhang H et al. (1993) p21 is a universal inhibitor of cyclin kinases. Nature 366:701-4
40. Yang A, Schweitzer R, Sun D et al. (1999) p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398:714-8
41. Yuspa SH (1994) The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis-Thirty-Third G. H. A. Clowes Memorial Award Lecture. Cancer Res 54:1178-89
42. Zhang D, Lin J, Han J (2010) Receptor-interacting protein (RIP) kinase family. Cell Mol Immunol 7:243-9